Objective Extramedullary myeloid cell tumors (EMCTs) may be unsuspected clinically and
difficult to recognize histologically. Fresh or frozen tissue is often not available for analysis …

In an attempt to correlate the morphologic and immunophenotypic findings in extramedullary
myeloid cell tumors (EMT), we studied 28 cases with a large panel of antibodies using …

Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare
condition, most often associated with acute myeloid leukemia (AML), although in some rare …

Abstract Purpose of Review The purpose of this review is to summarize the current literature
on the presentation, diagnosis, and treatment options available for extramedullary (EM) …

A patient with a 17-month history of myelodysplastic syndrome (refractory anemia with
excess blasts that evolved into chronic myelomonocytic leukemia), which was treated with …

Myeloid sarcoma (MS) is a subgroup of acute myeloid leukemia (AML) where myeloid blasts
form a tumoral mass in extramedullary tissues [1]. MS may occur at any point during the …

Myeloid sarcoma in acute myeloid leukemia has been clearly defined by the World Health
Organization but studies regarding the prevalence and the prognostic impact of …

Abstract Context.-Myeloid sarcoma (MS) is a neoplasm of immature granulocytes,
monocytes, or both involving any extramedullary site. The correct diagnosis of MS is …

Myeloid sarcoma (MS) is a rare neoplasm whose knowledge is largely based on case
reports and/or technically dated contributions. Ninety-two MSs in adulthood with clinical data …

Extramedullary (EM) manifestations of acute leukemia include a wide variety of clinically
significant phenomena that often pose therapeutic dilemmas. Myeloid sarcoma (MS) and …